FDA Consumer Health Product Enforcement Roundup
This article was originally published in The Tan Sheet
Executive Summary
New Zealand firm’s misbranded sunscreens, GMP problems; concussion treatment claims for Re:Mind; DMBA spotted in TruVision supplements; ED ingredient in Rhino supplements, other recalls; and formula selenium level effective date.
You may also be interested in...
Water Making Cancer Claim On Import Alert: Health And Wellness Industry News
TruVision warned on GMPs; UK regulators tell TV personality to disclose her social media endorsement of vitamin firm Convits; ThermoLife’s six-year litigation against Gaspari ends; and more news in brief.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.